The Valley Desk

NCT06455449 · Interventional trial

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Overall registry status Recruiting

Phase 3

Conditions Polymyositis, Dermatomyositis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov